Journal of Southern Medical University ›› 2025, Vol. 45 ›› Issue (1): 10-17.doi: 10.12122/j.issn.1673-4254.2025.01.02
Previous Articles Next Articles
					
													Shenyao ZHANG1,3( ), Min LU1,2(
), Min LU1,2( ), Gaoyan KUANG1,2, Xiaotong XU1,2, Jun FU1, Churan ZENG1
), Gaoyan KUANG1,2, Xiaotong XU1,2, Jun FU1, Churan ZENG1
												  
						
						
						
					
				
Received:2024-08-21
															
							
															
							
															
							
																	Online:2025-01-20
															
							
																	Published:2025-01-20
															
						Contact:
								Min LU   
																	E-mail:dirkzhang8627@hnucm.edu.cn;lumin6563@163.com
																					Shenyao ZHANG, Min LU, Gaoyan KUANG, Xiaotong XU, Jun FU, Churan ZENG. HDAC1 overexpression inhibits steroid-induced apoptosis of mouse osteocyte-like MLO-Y4 cells by inducing SP1 deacetylation[J]. Journal of Southern Medical University, 2025, 45(1): 10-17.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.j-smu.com/EN/10.12122/j.issn.1673-4254.2025.01.02
 
																													Fig.1 Cell apoptosis and HDAC1 expression in control and dexamethasone-treated mouse osteocyte-like MLO-Y4 cells. A: Cell apoptosis detected by flow cytometry. B: Expression levels of cleaved caspase-3, Bax and HDAC1 in the cells detected by Western blotting. **P<0.01, ***P<0.001.
| Group | Treatment time (h) | F P | |||
|---|---|---|---|---|---|
| 24 | 48 | 72 | |||
| Control | 0.59±0.07 | 1.12±0.09 | 1.25±0.09 | 52.89 | 0.009 | 
| Steroid | 0.55±0.09 | 0.76±0.08 | 0.95±0.09 | 27.32 | 0.028 | 
| t | 0.501 | 4.299 | 3.308 | ||
| P | 0.643 | 0.013 | 0.03 | ||
Tab.1 A450 nm in MLO-Y4 cells in CCK-8 assay 24, 48 and 72 h after dexamethasone treatment (n=3, Mean±SD)
| Group | Treatment time (h) | F P | |||
|---|---|---|---|---|---|
| 24 | 48 | 72 | |||
| Control | 0.59±0.07 | 1.12±0.09 | 1.25±0.09 | 52.89 | 0.009 | 
| Steroid | 0.55±0.09 | 0.76±0.08 | 0.95±0.09 | 27.32 | 0.028 | 
| t | 0.501 | 4.299 | 3.308 | ||
| P | 0.643 | 0.013 | 0.03 | ||
 
																													Fig.2 Identification of transfection efficiency of HDAC1 overexpression vector. A: qPCR for HDAC1 expression; B: western blot for HDAC1 protein. *P < 0.05, ***P<0.001.
 
																													Fig.3 Up-regulation of HDAC1 inhibits apoptosis of dexamethasone-treated MLO-Y4 cells. A: Cell apoptosis detected by flow cytometry. B: Expressions of cleaved caspase-3 and Bax detected by Western blotting. *P<0.05, ***P<0.001.
| Group | Treatment time (h) | F | P | ||
|---|---|---|---|---|---|
| 24 | 48 | 72 | |||
| Steroid | 0.56±0.07 | 0.79±0.09 | 0.96±0.11 | 47.72 | 0.016 | 
| Steroid+oe-NC | 0.45±0.04 | 0.80±0.09 | 0.97±0.12 | 15.12 | 0.048 | 
| Steroid+oe-HDAC1 | 0.59±0.08* | 1.15±0.11* | 1.32±0.10* | 30.63 | 0.031 | 
| F | 2.177 | 8.92 | 7.279 | ||
| P | 0.195 | 0.016 | 0.025 | ||
Tab.2 A450 nm at 24, 48 and 72 h after the transfection of HDAC1 overexpressing vector
| Group | Treatment time (h) | F | P | ||
|---|---|---|---|---|---|
| 24 | 48 | 72 | |||
| Steroid | 0.56±0.07 | 0.79±0.09 | 0.96±0.11 | 47.72 | 0.016 | 
| Steroid+oe-NC | 0.45±0.04 | 0.80±0.09 | 0.97±0.12 | 15.12 | 0.048 | 
| Steroid+oe-HDAC1 | 0.59±0.08* | 1.15±0.11* | 1.32±0.10* | 30.63 | 0.031 | 
| F | 2.177 | 8.92 | 7.279 | ||
| P | 0.195 | 0.016 | 0.025 | ||
 
																													Fig.5 Regulation of protein acetylation levels by the HDAC1 axis. A: Cellular acetylation levels detected by immunoprecipitation assay and Western blotting. B: SP1 protein detected by Western blotting. *P<0.05, **P<0.01.
| 1 | Chang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis[J]. J Autoimmun, 2020, 110: 102460. | 
| 2 | Motta F, Timilsina S, Gershwin ME, et al. Steroid-induced osteonecrosis[J]. J Transl Autoimmun, 2022, 5: 100168. | 
| 3 | Huang C, Wen ZQ, Niu JJ, et al. Steroid-induced osteonecrosis of the femoral head: novel insight into the roles of bone endothelial cells in pathogenesis and treatment[J]. Front Cell Dev Biol, 2021, 9: 777697. | 
| 4 | Zhang SQ, Wang CB, Shi L, et al. Beware of steroid-induced avascular necrosis of the femoral head in the treatment of COVID-19-experience and lessons from the SARS epidemic[J]. Drug Des Devel Ther, 2021, 15: 983-95. | 
| 5 | Kimura K, Jackson TLB, Huang RCC. Interaction and collaboration of SP1, HIF-1, and MYC in regulating the expression of cancer-related genes to further enhance anticancer drug development[J]. Curr Issues Mol Biol, 2023, 45(11): 9262-83. | 
| 6 | Yu X, Rong PZ, Song MS, et al. lncRNA SNHG1 induced by SP1 regulates bone remodeling and angiogenesis via sponging miR-181c-5p and modulating SFRP1/Wnt signaling pathway[J]. Mol Med, 2021, 27(1): 141. | 
| 7 | 卢 敏, 许晓彤, 申 楠, 等. 黄芪多糖对激素性股骨头坏死模型骨细胞凋亡和SP1/MEK/ERK轴的影响[J]. 中国现代医学杂志, 2023, 33(12): 33-40. | 
| 8 | Parveen R, Harihar D, Chatterji BP. Recent histone deacetylase inhibitors in cancer therapy[J]. Cancer, 2023, 129(21): 3372-80. | 
| 9 | Banerjee A, Mahata B, Dhir A, et al. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma[J]. J Biol Chem, 2019, 294(3): 1005-18. | 
| 10 | Duan P, Wang HY, Yi X, et al. C/EBPα regulates the fate of bone marrow mesenchymal stem cells and steroid-induced avascular necrosis of the femoral head by targeting the PPARγ signalling pathway[J]. Stem Cell Res Ther, 2022, 13(1): 342. | 
| 11 | Al-Omari AA, Aleshawi AJ, Marei OA, et al. Avascular necrosis of the femoral head after single steroid intra-articular injection[J]. Eur J Orthop Surg Traumatol, 2020, 30(2): 193-7. | 
| 12 | Fan ZQ, Bai SC, Xu Q, et al. Oxidative stress induced osteocyte apoptosis in steroid-induced femoral head necrosis[J]. Orthop Surg, 2021, 13(7): 2145-52. | 
| 13 | Li GQ, Wang ZY. MiR-20b promotes osteocyte apoptosis in rats with steroid-induced necrosis of the femoral head through BMP signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23(11): 4599-608. | 
| 14 | 李昊然, 高 璐, 迟湘胤, 等. 糖皮质激素性骨质疏松症的药物作用机制研究进展[J]. 中国骨质疏松杂志, 2021, 27(6): 910-3, 921. | 
| 15 | Xu K, Lu C, Ren XY, et al. Overexpression of HIF-1α enhances the protective effect of mitophagy on steroid-induced osteocytes apoptosis[J]. Environ Toxicol, 2021, 36(11): 2123-37. | 
| 16 | Jiang JF, Zhou ZY, Liu YZ, et al. Role of Sp1 in atherosclerosis[J]. Mol Biol Rep, 2022, 49(10): 9893-902. | 
| 17 | Safe S. Specificity proteins (sp) and cancer[J]. Int J Mol Sci, 2023, 24(6): 5164. | 
| 18 | Cai Y, Zhang MM, Wang M, et al. Bone marrow-derived mesenchymal stem cell-derived exosomes containing Gli1 alleviate microglial activation and neuronal apoptosis in vitro and in a mouse parkinson disease model by direct inhibition of Sp1 signaling[J]. J Neuropathol Exp Neurol, 2022, 81(7): 522-34. | 
| 19 | Zhang P, Li YN, Tu S, et al. SP1-induced lncRNA TUG1 regulates proliferation and apoptosis in islet cells of type 2 diabetes mellitus via the miR-188-3p/FGF5 axis[J]. Eur Rev Med Pharmacol Sci, 2021, 25(4): 1959-66. | 
| 20 | Guo L, Fang L, Liu Y. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer[J]. Eur Rev Med Pharmacol Sci, 2019, 23(20): 8913-20. | 
| 21 | Liu D, Wang YQ, Pan ZY, et al. cAMP regulates 11β-hydroxysteroid dehydrogenase-2 and Sp1 expression in MLO-Y4/MC3T3-E1 cells[J]. Exp Ther Med, 2020, 20(3): 2166-72. | 
| 22 | Zhang SY, Dong KF, Zeng XJ, et al. Astragalus polysaccharide ameliorates steroid-induced osteonecrosis of the femoral head by regulating miR-200b-3p-mediated Wnt/β-catenin signaling pathway via inhibiting SP1 expression: Astragalus polysaccharide regulates SONFH via SP1[J]. BMC Musculoskelet Disord, 2023, 24(1): 369. | 
| 23 | Dunaway LS, Pollock JS. HDAC1: an environmental sensor regulating endothelial function[J]. Cardiovasc Res, 2022, 118(8): 1885-903. | 
| 24 | Wang YF, Wang HY. The emerging role of histone deacetylase 1 in allergic diseases[J]. Front Immunol, 2022, 13: 1027403. | 
| 25 | Jain R, Epstein JA. Epigenetics[J]. Adv Exp Med Biol, 2024, 1441: 341-64. | 
| 26 | Sun ZH, Ma YF, Liu Y, et al. The acetylation modification of SP1 regulates the protein stability in silkworm[J]. Appl Biochem Biotechnol, 2022, 194(4): 1621-35. | 
| 27 | Yang WB, Hsu CC, Hsu TI, et al. Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma[J]. Neuro Oncol, 2020, 22(10): 1439-51. | 
| 28 | Ran XH, Zhu JW, Ni RZ, et al. TRIM5α recruits HDAC1 to p50 and Sp1 and promotes H3K9 deacetylation at the HIV-1 LTR[J]. Nat Commun, 2023, 14(1): 3343. | 
| 29 | Qiu Y, Zhao YM, Becker M, et al. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription[J]. Mol Cell, 2006, 22(5): 669-79. | 
| 30 | Kuzmochka C, Abdou HS, Haché RJG, et al. Inactivation of histone deacetylase 1 (HDAC1) but not HDAC2 is required for the gluco-corticoid-dependent CCAAT/enhancer-binding protein α (C/EBPα) expression and preadipocyte differentiation[J]. Endocrinology, 2014, 155(12): 4762-73. | 
| 31 | Wen YX, Shi HS, Wu ZX, et al. GR/Sp3/HDAC1/UGDH signaling participated in the maternal dexamethasone-induced dysplasia of the rat fetal growth plate[J]. FASEB J, 2020, 34(9): 12834-46. | 
| Viewed | ||||||
| Full text |  | |||||
| Abstract |  | |||||